Exploration: Nanoparticles in the Diagnosis and Treatment of Retinal Diseases

In recent years, research on nanoparticles (NPs) has brought a new phase in the development of medicine. The term “NPs” refers to nanoscale particles, typically between 10 and 1,000 nm size, that are within range cellular molecular structures. Compared with traditional ophthalmic drugs, NPs can carry drugs overcome obstacles, target drug delivery, prolong release, reduce toxicity, be used gene therapy. After brief introduction classification NPs, we will focus potential applications different diagnosis treatment retinal diseases introduce innovative methods derived from NPs.